Recombinant Human GITR Ligand/TNFSF18 Trimer Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02118P-100UG
Human GITR Ligand (Trimer) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human GITR Ligand/TNFSF18 Trimer Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02118P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human GITR Ligand/TNFSF18 Trimer Protein is expressed from HEK293 with monomeric hFc tag at the N-Terminus.It contains Gln50-Ser177. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9UNG2 |
Target Symbol | GITR Ligand/TNFSF18 Trimer |
Synonyms | TNFSF18; AITRL; TL6; GITRL; GITR Ligand |
Species | Human |
Expression System | HEK293 |
Tag | N-monomeric hFc |
Expression Range | Gln50-Ser177 |
Mol. Weight | The protein has a predicted MW of 70.2 kDa. Due to glycosylation, the protein migrates to 75-85 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | The affinity constant of 4.47 nM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Glucocorticoid-induced TNFR-related protein (TNFRSF18, GITR, CD357), expressed by T cells, and its ligand (TNFSF18, GITRL), expressed by myeloid populations, provide co-stimulatory signals that boost T cell activity. Due to the important role that GITR plays in regulating immune functions, agonistic stimulation of GITR is a promising therapeutic concept. |